Services industry

Pemetrexed Drug Market 2020 By Manufacturers, Regions, Types, Applications And Forecast To 2026

  • Code : SMI27459
  • Pages : 116
  • Date : Aug, 2020
  • Category : Services
  • |
  • Publisher : SMI



 

Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Summary

The global Pemetrexed Drug Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2019. 

The Pemetrexed Drug Market report highlights product development and growth strategies such as merger and acquisition adopted by market players along with SWOT Analysis, PEST and Porter’s Five Forces analyses of the Pemetrexed Drug Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.

The Key Manufacturers covered in this Report:-

  • Eli Lilly and Company
  • Pfizer
  • Teva
  • Eagle Pharmaceuticals
  • APOTEX
  • Qilu Pharmaceutical
  • Biocon
  • ...

By the Product Type, the market is primarily segmented into:

  • 100 mg lyophilized powder/vial
  • 500 mg lyophilized powder/vial

By Applications, the market is segmented into:

  • Pleural mesothelioma
  • Non-small cell lung cancer

The Report covers the following Regions:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Philippines
    • Vietnam
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Central & South America
    • Brazil
  • Middle East & Africa
    • Turkey
    • GCC Countries
    • Egypt
    • South Africa

Objective of the Pemetrexed Drug Market Report:

  • To assess the size of the market by value and volume
  • Analyze the Pemetrexed Drug Market in terms of regions and major countries
  • Highlight recent developments and trends in the market
  • Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
  • Determine share of the Pemetrexed Drug Market in terms of various segments such as by product type, application, and end-user
  • Offer accurate projection of the market for the forecast period using state-of –the-art tools and the current primary and secondary research approaches
  • Discuss major factors that impact growth of the Pemetrexed Drug Market

The Pemetrexed Drug Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Pemetrexed Drug Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders:

  • Material suppliers/wholesalers
  • Market Distributors/traders
  • Regulatory bodies
  • Research organizations, and consulting firms
  • Commercial research & developments (R&D)
  • Trade associations and industry bodies
  • Importers and exporters
  • End-use industries

Available Customizations:

Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

1 Study Coverage
1.1 Pemetrexed Drug Product Introduction
1.2 Market Segments
1.3 Key Pemetrexed Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Pemetrexed Drug Market Size Growth Rate by Type
1.4.2 100 mg lyophilized powder/vial
1.4.3 500 mg lyophilized powder/vial
1.5 Market by Application
1.5.1 Global Pemetrexed Drug Market Size Growth Rate by Application
1.5.2 Pleural mesothelioma
1.5.3 Non-small cell lung cancer
1.6 Coronavirus Disease 2019 (Covid-19): Pemetrexed Drug Industry Impact
1.6.1 How the Covid-19 is Affecting the Pemetrexed Drug Industry
1.6.1.1 Pemetrexed Drug Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Pemetrexed Drug Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Pemetrexed Drug Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 Executive Summary
2.1 Global Pemetrexed Drug Market Size Estimates and Forecasts
2.1.1 Global Pemetrexed Drug Revenue 2015-2026
2.1.2 Global Pemetrexed Drug Sales 2015-2026
2.2 Pemetrexed Drug Market Size by Region: 2020 Versus 2026
2.2.1 Global Pemetrexed Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Pemetrexed Drug Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Pemetrexed Drug Competitor Landscape by Players
3.1 Pemetrexed Drug Sales by Manufacturers
3.1.1 Pemetrexed Drug Sales by Manufacturers (2015-2020)
3.1.2 Pemetrexed Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Pemetrexed Drug Revenue by Manufacturers
3.2.1 Pemetrexed Drug Revenue by Manufacturers (2015-2020)
3.2.2 Pemetrexed Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Pemetrexed Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Pemetrexed Drug Revenue in 2019
3.2.5 Global Pemetrexed Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Pemetrexed Drug Price by Manufacturers
3.4 Pemetrexed Drug Manufacturing Base Distribution, Product Types
3.4.1 Pemetrexed Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pemetrexed Drug Product Type
3.4.3 Date of International Manufacturers Enter into Pemetrexed Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)
4.1 Global Pemetrexed Drug Market Size by Type (2015-2020)
4.1.1 Global Pemetrexed Drug Sales by Type (2015-2020)
4.1.2 Global Pemetrexed Drug Revenue by Type (2015-2020)
4.1.3 Pemetrexed Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Pemetrexed Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Pemetrexed Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Pemetrexed Drug Revenue Forecast by Type (2021-2026)
4.2.3 Pemetrexed Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Pemetrexed Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)
5.1 Global Pemetrexed Drug Market Size by Application (2015-2020)
5.1.1 Global Pemetrexed Drug Sales by Application (2015-2020)
5.1.2 Global Pemetrexed Drug Revenue by Application (2015-2020)
5.1.3 Pemetrexed Drug Price by Application (2015-2020)
5.2 Pemetrexed Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Pemetrexed Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Pemetrexed Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Pemetrexed Drug Price Forecast by Application (2021-2026)

6 North America
6.1 North America Pemetrexed Drug by Country
6.1.1 North America Pemetrexed Drug Sales by Country
6.1.2 North America Pemetrexed Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Pemetrexed Drug Market Facts & Figures by Type
6.3 North America Pemetrexed Drug Market Facts & Figures by Application

7 Europe
7.1 Europe Pemetrexed Drug by Country
7.1.1 Europe Pemetrexed Drug Sales by Country
7.1.2 Europe Pemetrexed Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Pemetrexed Drug Market Facts & Figures by Type
7.3 Europe Pemetrexed Drug Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Pemetrexed Drug by Region
8.1.1 Asia Pacific Pemetrexed Drug Sales by Region
8.1.2 Asia Pacific Pemetrexed Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Pemetrexed Drug Market Facts & Figures by Type
8.3 Asia Pacific Pemetrexed Drug Market Facts & Figures by Application

9 Latin America
9.1 Latin America Pemetrexed Drug by Country
9.1.1 Latin America Pemetrexed Drug Sales by Country
9.1.2 Latin America Pemetrexed Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Pemetrexed Drug Market Facts & Figures by Type
9.3 Central & South America Pemetrexed Drug Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Pemetrexed Drug by Country
10.1.1 Middle East and Africa Pemetrexed Drug Sales by Country
10.1.2 Middle East and Africa Pemetrexed Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Pemetrexed Drug Market Facts & Figures by Type
10.3 Middle East and Africa Pemetrexed Drug Market Facts & Figures by Application

11 Company Profiles
11.1 Eli Lilly and Company
11.1.1 Eli Lilly and Company Corporation Information
11.1.2 Eli Lilly and Company Description, Business Overview and Total Revenue
11.1.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Eli Lilly and Company Pemetrexed Drug Products Offered
11.1.5 Eli Lilly and Company Recent Development
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Description, Business Overview and Total Revenue
11.2.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Pfizer Pemetrexed Drug Products Offered
11.2.5 Pfizer Recent Development
11.3 Teva
11.3.1 Teva Corporation Information
11.3.2 Teva Description, Business Overview and Total Revenue
11.3.3 Teva Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Teva Pemetrexed Drug Products Offered
11.3.5 Teva Recent Development
11.4 Eagle Pharmaceuticals
11.4.1 Eagle Pharmaceuticals Corporation Information
11.4.2 Eagle Pharmaceuticals Description, Business Overview and Total Revenue
11.4.3 Eagle Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Eagle Pharmaceuticals Pemetrexed Drug Products Offered
11.4.5 Eagle Pharmaceuticals Recent Development
11.5 APOTEX
11.5.1 APOTEX Corporation Information
11.5.2 APOTEX Description, Business Overview and Total Revenue
11.5.3 APOTEX Sales, Revenue and Gross Margin (2015-2020)
11.5.4 APOTEX Pemetrexed Drug Products Offered
11.5.5 APOTEX Recent Development
11.6 Qilu Pharmaceutical
11.6.1 Qilu Pharmaceutical Corporation Information
11.6.2 Qilu Pharmaceutical Description, Business Overview and Total Revenue
11.6.3 Qilu Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Qilu Pharmaceutical Pemetrexed Drug Products Offered
11.6.5 Qilu Pharmaceutical Recent Development
11.7 Biocon
11.7.1 Biocon Corporation Information
11.7.2 Biocon Description, Business Overview and Total Revenue
11.7.3 Biocon Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Biocon Pemetrexed Drug Products Offered
11.7.5 Biocon Recent Development
11.1 Eli Lilly and Company
11.1.1 Eli Lilly and Company Corporation Information
11.1.2 Eli Lilly and Company Description, Business Overview and Total Revenue
11.1.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Eli Lilly and Company Pemetrexed Drug Products Offered
11.1.5 Eli Lilly and Company Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Pemetrexed Drug Market Estimates and Projections by Region
12.1.1 Global Pemetrexed Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Pemetrexed Drug Revenue Forecast by Regions 2021-2026
12.2 North America Pemetrexed Drug Market Size Forecast (2021-2026)
12.2.1 North America: Pemetrexed Drug Sales Forecast (2021-2026)
12.2.2 North America: Pemetrexed Drug Revenue Forecast (2021-2026)
12.2.3 North America: Pemetrexed Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Pemetrexed Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Pemetrexed Drug Sales Forecast (2021-2026)
12.3.2 Europe: Pemetrexed Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Pemetrexed Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Pemetrexed Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Pemetrexed Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Pemetrexed Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Pemetrexed Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Pemetrexed Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Pemetrexed Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Pemetrexed Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Pemetrexed Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Pemetrexed Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Pemetrexed Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Pemetrexed Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Pemetrexed Drug Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porters Five Forces Analysis
13.5 Primary Interviews with Key Pemetrexed Drug Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Pemetrexed Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details

List of Table
List of Tables
Table 1. Pemetrexed Drug Market Segments
Table 2. Ranking of Global Top Pemetrexed Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Pemetrexed Drug Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of 100 mg lyophilized powder/vial
Table 5. Major Manufacturers of 500 mg lyophilized powder/vial
Table 6. COVID-19 Impact Global Market: (Four Pemetrexed Drug Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Pemetrexed Drug Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Pemetrexed Drug Players to Combat Covid-19 Impact
Table 11. Global Pemetrexed Drug Market Size Growth Rate by Application 2020-2026 (K Units)
Table 12. Global Pemetrexed Drug Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 13. Global Pemetrexed Drug Sales by Regions 2015-2020 (K Units)
Table 14. Global Pemetrexed Drug Sales Market Share by Regions (2015-2020)
Table 15. Global Pemetrexed Drug Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Pemetrexed Drug Sales by Manufacturers (2015-2020) (K Units)
Table 17. Global Pemetrexed Drug Sales Share by Manufacturers (2015-2020)
Table 18. Global Pemetrexed Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Pemetrexed Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pemetrexed Drug as of 2019)
Table 20. Pemetrexed Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Pemetrexed Drug Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Pemetrexed Drug Price (2015-2020) (USD/Unit)
Table 23. Pemetrexed Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Pemetrexed Drug Product Type
Table 25. Date of International Manufacturers Enter into Pemetrexed Drug Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Pemetrexed Drug Sales by Type (2015-2020) (K Units)
Table 28. Global Pemetrexed Drug Sales Share by Type (2015-2020)
Table 29. Global Pemetrexed Drug Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Pemetrexed Drug Revenue Share by Type (2015-2020)
Table 31. Pemetrexed Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 32. Global Pemetrexed Drug Sales by Application (2015-2020) (K Units)
Table 33. Global Pemetrexed Drug Sales Share by Application (2015-2020)
Table 34. North America Pemetrexed Drug Sales by Country (2015-2020) (K Units)
Table 35. North America Pemetrexed Drug Sales Market Share by Country (2015-2020)
Table 36. North America Pemetrexed Drug Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Pemetrexed Drug Revenue Market Share by Country (2015-2020)
Table 38. North America Pemetrexed Drug Sales by Type (2015-2020) (K Units)
Table 39. North America Pemetrexed Drug Sales Market Share by Type (2015-2020)
Table 40. North America Pemetrexed Drug Sales by Application (2015-2020) (K Units)
Table 41. North America Pemetrexed Drug Sales Market Share by Application (2015-2020)
Table 42. Europe Pemetrexed Drug Sales by Country (2015-2020) (K Units)
Table 43. Europe Pemetrexed Drug Sales Market Share by Country (2015-2020)
Table 44. Europe Pemetrexed Drug Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Pemetrexed Drug Revenue Market Share by Country (2015-2020)
Table 46. Europe Pemetrexed Drug Sales by Type (2015-2020) (K Units)
Table 47. Europe Pemetrexed Drug Sales Market Share by Type (2015-2020)
Table 48. Europe Pemetrexed Drug Sales by Application (2015-2020) (K Units)
Table 49. Europe Pemetrexed Drug Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Pemetrexed Drug Sales by Region (2015-2020) (K Units)
Table 51. Asia Pacific Pemetrexed Drug Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Pemetrexed Drug Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Pemetrexed Drug Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Pemetrexed Drug Sales by Type (2015-2020) (K Units)
Table 55. Asia Pacific Pemetrexed Drug Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Pemetrexed Drug Sales by Application (2015-2020) (K Units)
Table 57. Asia Pacific Pemetrexed Drug Sales Market Share by Application (2015-2020)
Table 58. Latin America Pemetrexed Drug Sales by Country (2015-2020) (K Units)
Table 59. Latin America Pemetrexed Drug Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Pemetrexed Drug Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Pemetrexed Drug Revenue Market Share by Country (2015-2020)
Table 62. Latin America Pemetrexed Drug Sales by Type (2015-2020) (K Units)
Table 63. Latin America Pemetrexed Drug Sales Market Share by Type (2015-2020)
Table 64. Latin America Pemetrexed Drug Sales by Application (2015-2020) (K Units)
Table 65. Latin America Pemetrexed Drug Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Pemetrexed Drug Sales by Country (2015-2020) (K Units)
Table 67. Middle East and Africa Pemetrexed Drug Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Pemetrexed Drug Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Pemetrexed Drug Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Pemetrexed Drug Sales by Type (2015-2020) (K Units)
Table 71. Middle East and Africa Pemetrexed Drug Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Pemetrexed Drug Sales by Application (2015-2020) (K Units)
Table 73. Middle East and Africa Pemetrexed Drug Sales Market Share by Application (2015-2020)
Table 74. Eli Lilly and Company Corporation Information
Table 75. Eli Lilly and Company Description and Major Businesses
Table 76. Eli Lilly and Company Pemetrexed Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Eli Lilly and Company Product
Table 78. Eli Lilly and Company Recent Development
Table 79. Pfizer Corporation Information
Table 80. Pfizer Description and Major Businesses
Table 81. Pfizer Pemetrexed Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Pfizer Product
Table 83. Pfizer Recent Development
Table 84. Teva Corporation Information
Table 85. Teva Description and Major Businesses
Table 86. Teva Pemetrexed Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Teva Product
Table 88. Teva Recent Development
Table 89. Eagle Pharmaceuticals Corporation Information
Table 90. Eagle Pharmaceuticals Description and Major Businesses
Table 91. Eagle Pharmaceuticals Pemetrexed Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Eagle Pharmaceuticals Product
Table 93. Eagle Pharmaceuticals Recent Development
Table 94. APOTEX Corporation Information
Table 95. APOTEX Description and Major Businesses
Table 96. APOTEX Pemetrexed Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. APOTEX Product
Table 98. APOTEX Recent Development
Table 99. Qilu Pharmaceutical Corporation Information
Table 100. Qilu Pharmaceutical Description and Major Businesses
Table 101. Qilu Pharmaceutical Pemetrexed Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Qilu Pharmaceutical Product
Table 103. Qilu Pharmaceutical Recent Development
Table 104. Biocon Corporation Information
Table 105. Biocon Description and Major Businesses
Table 106. Biocon Pemetrexed Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Biocon Product
Table 108. Biocon Recent Development
Table 109. Global Pemetrexed Drug Sales Forecast by Regions (2021-2026) (K Units)
Table 110. Global Pemetrexed Drug Sales Market Share Forecast by Regions (2021-2026)
Table 111. Global Pemetrexed Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 112. Global Pemetrexed Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 113. North America: Pemetrexed Drug Sales Forecast by Country (2021-2026) (K Units)
Table 114. North America: Pemetrexed Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Europe: Pemetrexed Drug Sales Forecast by Country (2021-2026) (K Units)
Table 116. Europe: Pemetrexed Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 117. Asia Pacific: Pemetrexed Drug Sales Forecast by Region (2021-2026) (K Units)
Table 118. Asia Pacific: Pemetrexed Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 119. Latin America: Pemetrexed Drug Sales Forecast by Country (2021-2026) (K Units)
Table 120. Latin America: Pemetrexed Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Middle East and Africa: Pemetrexed Drug Sales Forecast by Country (2021-2026) (K Units)
Table 122. Middle East and Africa: Pemetrexed Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 124. Key Challenges
Table 125. Market Risks
Table 126. Main Points Interviewed from Key Pemetrexed Drug Players
Table 127. Pemetrexed Drug Customers List
Table 128. Pemetrexed Drug Distributors List
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Pemetrexed Drug Product Picture
Figure 2. Global Pemetrexed Drug Sales Market Share by Type in 2020 & 2026
Figure 3. 100 mg lyophilized powder/vial Product Picture
Figure 4. 500 mg lyophilized powder/vial Product Picture
Figure 5. Global Pemetrexed Drug Sales Market Share by Application in 2020 & 2026
Figure 6. Pleural mesothelioma
Figure 7. Non-small cell lung cancer
Figure 8. Pemetrexed Drug Report Years Considered
Figure 9. Global Pemetrexed Drug Market Size 2015-2026 (US$ Million)
Figure 10. Global Pemetrexed Drug Sales 2015-2026 (K Units)
Figure 11. Global Pemetrexed Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Pemetrexed Drug Sales Market Share by Region (2015-2020)
Figure 13. Global Pemetrexed Drug Sales Market Share by Region in 2019
Figure 14. Global Pemetrexed Drug Revenue Market Share by Region (2015-2020)
Figure 15. Global Pemetrexed Drug Revenue Market Share by Region in 2019
Figure 16. Global Pemetrexed Drug Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Pemetrexed Drug Revenue in 2019
Figure 18. Pemetrexed Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Pemetrexed Drug Sales Market Share by Type (2015-2020)
Figure 20. Global Pemetrexed Drug Sales Market Share by Type in 2019
Figure 21. Global Pemetrexed Drug Revenue Market Share by Type (2015-2020)
Figure 22. Global Pemetrexed Drug Revenue Market Share by Type in 2019
Figure 23. Global Pemetrexed Drug Market Share by Price Range (2015-2020)
Figure 24. Global Pemetrexed Drug Sales Market Share by Application (2015-2020)
Figure 25. Global Pemetrexed Drug Sales Market Share by Application in 2019
Figure 26. Global Pemetrexed Drug Revenue Market Share by Application (2015-2020)
Figure 27. Global Pemetrexed Drug Revenue Market Share by Application in 2019
Figure 28. North America Pemetrexed Drug Sales Growth Rate 2015-2020 (K Units)
Figure 29. North America Pemetrexed Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Pemetrexed Drug Sales Market Share by Country in 2019
Figure 31. North America Pemetrexed Drug Revenue Market Share by Country in 2019
Figure 32. U.S. Pemetrexed Drug Sales Growth Rate (2015-2020) (K Units)
Figure 33. U.S. Pemetrexed Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Pemetrexed Drug Sales Growth Rate (2015-2020) (K Units)
Figure 35. Canada Pemetrexed Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Pemetrexed Drug Market Share by Type in 2019
Figure 37. North America Pemetrexed Drug Market Share by Application in 2019
Figure 38. Europe Pemetrexed Drug Sales Growth Rate 2015-2020 (K Units)
Figure 39. Europe Pemetrexed Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Pemetrexed Drug Sales Market Share by Country in 2019
Figure 41. Europe Pemetrexed Drug Revenue Market Share by Country in 2019
Figure 42. Germany Pemetrexed Drug Sales Growth Rate (2015-2020) (K Units)
Figure 43. Germany Pemetrexed Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Pemetrexed Drug Sales Growth Rate (2015-2020) (K Units)
Figure 45. France Pemetrexed Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Pemetrexed Drug Sales Growth Rate (2015-2020) (K Units)
Figure 47. U.K. Pemetrexed Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Pemetrexed Drug Sales Growth Rate (2015-2020) (K Units)
Figure 49. Italy Pemetrexed Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Pemetrexed Drug Sales Growth Rate (2015-2020) (K Units)
Figure 51. Russia Pemetrexed Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Pemetrexed Drug Market Share by Type in 2019
Figure 53. Europe Pemetrexed Drug Market Share by Application in 2019
Figure 54. Asia Pacific Pemetrexed Drug Sales Growth Rate 2015-2020 (K Units)
Figure 55. Asia Pacific Pemetrexed Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Pemetrexed Drug Sales Market Share by Region in 2019
Figure 57. Asia Pacific Pemetrexed Drug Revenue Market Share by Region in 2019
Figure 58. China Pemetrexed Drug Sales Growth Rate (2015-2020) (K Units)
Figure 59. China Pemetrexed Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Pemetrexed Drug Sales Growth Rate (2015-2020) (K Units)
Figure 61. Japan Pemetrexed Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Pemetrexed Drug Sales Growth Rate (2015-2020) (K Units)
Figure 63. South Korea Pemetrexed Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Pemetrexed Drug Sales Growth Rate (2015-2020) (K Units)
Figure 65. India Pemetrexed Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Pemetrexed Drug Sales Growth Rate (2015-2020) (K Units)
Figure 67. Australia Pemetrexed Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Pemetrexed Drug Sales Growth Rate (2015-2020) (K Units)
Figure 69. Taiwan Pemetrexed Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Pemetrexed Drug Sales Growth Rate (2015-2020) (K Units)
Figure 71. Indonesia Pemetrexed Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Pemetrexed Drug Sales Growth Rate (2015-2020) (K Units)
Figure 73. Thailand Pemetrexed Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Pemetrexed Drug Sales Growth Rate (2015-2020) (K Units)
Figure 75. Malaysia Pemetrexed Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Pemetrexed Drug Sales Growth Rate (2015-2020) (K Units)
Figure 77. Philippines Pemetrexed Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Pemetrexed Drug Sales Growth Rate (2015-2020) (K Units)
Figure 79. Vietnam Pemetrexed Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Pemetrexed Drug Market Share by Type in 2019
Figure 81. Asia Pacific Pemetrexed Drug Market Share by Application in 2019
Figure 82. Latin America Pemetrexed Drug Sales Growth Rate 2015-2020 (K Units)
Figure 83. Latin America Pemetrexed Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Pemetrexed Drug Sales Market Share by Country in 2019
Figure 85. Latin America Pemetrexed Drug Revenue Market Share by Country in 2019
Figure 86. Mexico Pemetrexed Drug Sales Growth Rate (2015-2020) (K Units)
Figure 87. Mexico Pemetrexed Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Pemetrexed Drug Sales Growth Rate (2015-2020) (K Units)
Figure 89. Brazil Pemetrexed Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Pemetrexed Drug Sales Growth Rate (2015-2020) (K Units)
Figure 91. Argentina Pemetrexed Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Pemetrexed Drug Market Share by Type in 2019
Figure 93. Latin America Pemetrexed Drug Market Share by Application in 2019
Figure 94. Middle East and Africa Pemetrexed Drug Sales Growth Rate 2015-2020 (K Units)
Figure 95. Middle East and Africa Pemetrexed Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Pemetrexed Drug Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Pemetrexed Drug Revenue Market Share by Country in 2019
Figure 98. Turkey Pemetrexed Drug Sales Growth Rate (2015-2020) (K Units)
Figure 99. Turkey Pemetrexed Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Pemetrexed Drug Sales Growth Rate (2015-2020) (K Units)
Figure 101. Saudi Arabia Pemetrexed Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. U.A.E Pemetrexed Drug Sales Growth Rate (2015-2020) (K Units)
Figure 103. U.A.E Pemetrexed Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Pemetrexed Drug Market Share by Type in 2019
Figure 105. Middle East and Africa Pemetrexed Drug Market Share by Application in 2019
Figure 106. Eli Lilly and Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 107. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Eagle Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. APOTEX Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Qilu Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Biocon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. North America Pemetrexed Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. North America Pemetrexed Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Europe Pemetrexed Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Europe Pemetrexed Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Asia Pacific Pemetrexed Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. Asia Pacific Pemetrexed Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Latin America Pemetrexed Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 120. Latin America Pemetrexed Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Middle East and Africa Pemetrexed Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 122. Middle East and Africa Pemetrexed Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Porter's Five Forces Analysis
Figure 124. Channels of Distribution
Figure 125. Distributors Profiles
Figure 126. Bottom-up and Top-down Approaches for This Report
Figure 127. Data Triangulation
Figure 128. Key Executives Interviewed
 



Contact Us

U.S.A :  +1-415-871-0703

UK :  +44-203-289-4040

JAPAN :  +81-50-5539-1737


Drop Us an email at

[email protected]

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.